Quantcast

Latest pharmaceutical industry Stories

2014-09-04 12:21:31

Conference attendees get chance to discuss visibility, collaboration and brand protection challenges with the experts MARLTON, N.J., Sept. 4, 2014 /PRNewswire/ -- Acsis Inc., the market leader for supply chain visibility, brand protection and serialization solutions, announced the company will be attending two major pharmaceutical industry conferences in September - PDA/FDA Joint Regulatory Conference, September 8-9 at the Renaissance Hotel, Washington DC, Booth # 58; and LogiPharma,...

2014-09-04 08:30:35

ALBANY, N.Y., Sept. 4, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of about 4.1% to about $9.2 billion by 2018(1). AMRI's current and ongoing activities - as part of its New York State Public-Private Partnership in Buffalo, N.Y. - encompass the production of...

2014-09-04 08:30:00

LAUSANNE, Switzerland, September 4, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute...

2014-09-04 08:29:33

BOSTON, Sept. 4, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Dr. Tracy Tsuetaki as Senior Vice President for Peri/Post-Approval Services and PAREXEL Consulting. He will oversee the strategy and operational management for both businesses. He will also serve on PAREXEL's Business Review Committee, the Company's senior-most leadership team, and assist in developing and...

2014-09-03 08:35:17

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 3, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding United Therapeutics Corporation (NASDAQ: UTHR), Illumina, Inc. (NASDAQ: ILMN), AstraZeneca plc (NYSE: AZN), Eli Lilly and Co. (NYSE: LLY) and Abbott Laboratories (NYSE: ABT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings...

2014-09-03 08:34:10

Company CEO to present at both the Rodman & Renshaw Global Investment Conference and Aegis Capital 2014 Healthcare and Technology Conference in September JERUSALEM, September 3, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com [http://c/Users/Aviva - Oramed/EFN Synced Tool/.CORPORATE/Public Relations/PressReleases/Press Releases/2014/NEW RELEASES - checking/www.oramed.com ] ), a clinical-stage pharmaceutical company focused on the...

2014-09-03 08:33:41

PLYMOUTH MEETING, Pa., Sept. 3, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in New York, NY and at the Aegis Capital Healthcare and Technology Conference in Las Vegas, NV. Dr. J. Joseph Kim, Inovio's Chief Executive Officer, will provide a corporate overview of the Company and its programs at each of these events. Rodman & Renshaw Investment Conference September...

2014-09-03 08:33:15

Sweden is latest country to grant marketing authorization ATLANTA, Sept. 3, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Swedish Medical Products Agency has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME)...

2014-09-03 08:33:04

WOODCLIFF LAKE, N.J., Sept. 3, 2014 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced it has entered into an agreement with Concordia Pharmaceuticals Inc. ("Concordia"), a subsidiary of Concordia Healthcare Corp., to purchase Eisai's U.S. and Puerto Rican commercialization and distribution rights to Zonegran. As part of the deal terms, Eisai will receive full payment from Concordia upon closing. In addition, Eisai and Concordia are...

2014-09-03 08:32:21

SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Ajinomoto Althea, Inc. ("Althea"), a leading provider of biopharmaceutical contract development and manufacturing services announced today that it has officially received its European GMP certificate issued by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA conducted an on-site inspection on June 19, 2014 that yielded no critical or major observations. This certification provides clearance to Althea to test commercial...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.